Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries
- Written by PR Newswire
10+ Emerging Markets, Japan & ANZ Transition in Final Phase
KUALA LUMPUR, Malaysia, Dec. 18, 2023 /PRNewswire/ -- Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully concluded the integration of the acquired Viatris biosimilars business with...
Read more: Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries














